5 June 2018 - Real net drug prices fell more than 5% in the first quarter of the year, according to an analysis from SSR Health.
Drug prices fell more than 5% in the first quarter, a new analysis found. But what caused the decrease can actually increase costs for patients in the long run.
If it sounds wonky, that's because it is.
List price, or the advertised amount, of drugs increased 6.2%, according to SSR Health. Meanwhile, real net price declined 5.6%, compared with 1.7% in the same period last year, the firm found.